Ubiquoss Holdings: Low Multiples and Rising Profits, but the Share Price Has Fallen 27.4% Over One Year

Thesis

The data supports a picture of a profitable, nearly debt-free company whose earnings have recovered from 2024. Net income over the trailing twelve months reached ₩33.2B, up from ₩20.4B in 2025 and ₩8.9B in 2024. Cash of ₩109.8B against borrowings of ₩1.0B means the balance sheet is very conservative. Price multiples are low against both the company's own history and the listed peers shown.

What the data does not settle is why the market assigns such low multiples. The stock is 62.0% below its 52-week high of ₩21,550 and only 13.9% above the 52-week low of ₩7,200. Revenue has been uneven, with a 26.8% fall in 2024 followed by a 23.9% rise in 2025. The dividend yield shows as 0.0% even though cash dividend decisions appear in filings. No news headlines are available in the data.

Business overview

Ubiquoss Holdings is listed on KOSDAQ and classified in the data as a holding company. It was founded on 2000-07-11 and listed on 2009-01-23, with 17,058,843 listed shares. The data does not describe its products or subsidiaries, so the business mix is not available here. Revenue was ₩151.0B in 2021, ₩151.6B in 2022, ₩171.6B in 2023, ₩125.6B in 2024 and ₩155.7B in 2025. Foreign ownership is 2.3%, up from 2.2% sixty days ago, and the short balance is 0.2%.

Financial analysis

The figures below come from filed financial statements. Trailing-twelve-month revenue to H1 2026 is ₩159.4B, operating income is ₩34.6B and net income is ₩33.2B, giving an operating margin of 21.7% and a net margin of 20.8%. Return on equity is 12.4%, compared with 7.9% in 2025 and 3.6% in 2024.

Annual operating margin was 21.8% in 2021, 18.1% in 2022, 19.0% in 2023, 11.4% in 2024 and 19.7% in 2025. Liabilities are 9.5% of equity. Free cash flow over the trailing twelve months is ₩27.7B, and enterprise value is ₩31.1B because cash is large relative to market cap.

Valuation

The shares trade at 4.2x earnings, 0.5x book value, 0.9x sales and 0.8x EV/EBITDA. Year-end P/E was 9.0x in 2025, 19.3x in 2024 and 15.6x in 2023, and year-end P/B was 0.7x in 2025 and 0.9x to 1.2x in earlier years, so current multiples are below the company's own history. Among the listed peers, P/E ranges from 3.1x (SK Square) to 9.2x (KB Financial Group), and P/B from 0.7x to 1.9x. Ubiquoss's 0.5x P/B is below all of them, though these peers are mostly large financial or holding groups and are not like-for-like.

The valuation model uses the sum-of-the-parts (NAV) method for holding companies. It gives a model estimate based on the assumptions shown of ₩1,815 per share in the base case, ₩1,210 in the bear case and ₩2,541 in the bull case, using a 40.0% rate. All of these are well below the ₩8,200 share price. The result looks inconsistent with the low P/B and the large cash balance, so it should be read cautiously. It is not a target and not a reason to buy or sell.

Catalysts

• The half-year report filed on 2026-08-14 showed trailing profits rising to ₩33.2B, which investors may keep weighing.
• A share cancellation decision was filed on 2026-05-13, which relates to shareholder returns.
• Cash dividend decisions were filed on 2026-02-03 and amended on 2026-03-19, alongside shareholder return policy guidance.
• Over the past 20 days retail investors were net buyers of about ₩522M and institutions of about ₩69M, while foreigners were net sellers of about ₩204M.
• The next quarterly filing will show whether the recovery in margins continues.

Risks

• Revenue has swung from -26.8% in 2024 to +23.9% in 2025, so earnings may be volatile.
• The share price is down 27.4% over one year and 6.2% over one month, showing weak market sentiment.
• The model's NAV estimate of ₩1,815 base case is far below the market price, and the data does not explain the gap.
• The dividend yield is shown as 0.0%, so current cash returns to shareholders appear limited in the data.
• Foreign ownership is only 2.3% and recent foreign flows are negative, which may limit demand and liquidity.

Closing view

The data shows a company with strong recent profitability, little debt and a lot of cash, trading at low multiples relative to its own past and to the listed peers. Against that, the share price has fallen sharply, revenue has been uneven, and the model's NAV-based estimate sits well below the market price. The evidence is mixed rather than conclusive, and the data cannot show what is driving the market's low valuation. Investors would want to follow upcoming filings for the durability of margins and for shareholder return decisions.

Model estimate of fair value

Bear

₩1,210

-85%

Base

₩1,815

-77%

Bull

₩2,541

-68%

Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal.

Base case of the sum-of-the-parts (net asset value) model on the stock's Valuation tab (statements TTM to H1 2026; discount rate 40%). Bear and Bull move the main assumptions by fixed steps. See and change the assumptions

Filings and data used

• Half-year report (Jun 2026)Aug 14, 2026
• Quarterly report (Mar 2026)May 15, 2026
• Share cancellation decisionMay 13, 2026
• Amended: Cash dividend decisionMar 19, 2026
• Annual general meeting resultsMar 18, 2026
• Report on Appointment, Dismissal, or Mid-Term Resignation of Independent DirectorsMar 18, 2026
• Audit report submittedMar 10, 2026
• Annual report (Dec 2025)Mar 10, 2026
• Shareholders' meeting calledMar 3, 2026
• Notice of shareholders' meetingMar 3, 2026
• Matters Subject to Timely Disclosure Obligations (Fair Disclosure) (Shareholder Return Policy Guidance)Feb 3, 2026
• Cash dividend decisionFeb 3, 2026
• Daily prices up to 2026-10-19
• Financial statements, trailing 12 months as of H1 2026
• Our fair value model, statements as of TTM to H1 2026

Report history

1. Oct 20, 2026InitiationStart of coverage (reader request)Ubiquoss Holdings: Low Multiples and Rising Profits, but the Share Price Has Fallen 27.4% Over One Year